“The Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences plays a key role in the advancement of medicine in the UAE, and we are proud to be able to support the next generation of doctors with opportunities to enrich their knowledge to the benefit of patients”, said Dr. Andrew Bird, General Manager Acino Middle East & Africa.
The Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and Acino will work together to provide services in medical education, infrastructure development and management in health-related facilities, as well as in areas such as the harnessing of artificial intelligence in the context of healthcare.
Mr. Abdulla Bin Souqat, Executive Director of the Award added, “We are proud to collaborate with Acino. This partnership will allow both organisations to make considerable progress in their missions to improve the lives of patients”.
Together, both parties have planned a number of joint activities including a series of lectures to local medical undergraduates on topics such as quality assurance and quality control, where Acino is pioneering several technologies and methodologies. Medical students will also have the opportunity to visit Acino’s production facilities in Switzerland to better understand the production and quality requirements.
“Middle East & Africa is a key market for Acino, this partnership exemplifies our support and dedication to improve the healthcare for patients in UAE, and we look forward to a long and fruitful partnership”, said Steffen Saltofte, CEO Acino.
For more information, please contact Ayman ElKadi, Commercial Director, Middle East & Africa, tel: +971 4 556 5444, email: email@example.com
Please also visit the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences website.
On September 29, our team in Iraq held awareness and educational events in cardiac centers and malls to support our community on World Heart Day.
Partnering with the Iraqi Hypertension Society (IHS), the team spread awareness of cardiovascular diseases and how we can all take steps to reduce them.
World Heart Day is an annual, global event, which Acino takes part in to support patients and the public in the local communities. This year the team held educational sessions at three public malls and visited eight cardiac centers to support physicians and staff in spreading the message of a healthy heart through understanding, lifestyle tips and dietary approaches.
‘We are part of the healthcare system in Iraq and it is our duty to and support such events’, said Hayder Yahya, Senior Product Manager. ‘We take this role very seriously, and will continue to educate our patients and increase health awareness in collaboration with local societies’, he added.
We would like to thank the Iraqi Hypertension Society for their partnership on World Heart Day.
For more information on World Heart Day, please visit the World Heart Foundation’s website.
For more information on Hypertension, please visit the Iraqi Hypertension Society’s website.
On December 18, Acino completed the registration of the company as a legal entity in Turkey, paving the way to begin commercial operations in the country in 2020.
‘Following the signing of an agreement for Acino to acquire parts of Takeda’s primary care portfolio in selected countries, we are expanding our geographical presence to provide high-quality medicines in Turkey, one of the Middle-East’s biggest markets.’ explained Dr Andrew Bird, General Manager Acino Middle East and Africa.
In the Middle East, Acino provides high-quality medicines under the Acino Switzerland brand. The company’s existing capabilities, along with its therapeutic expertise especially in gastroenterology, cardiovascular and pain management will serve as a platform to introduce Acino’s portfolio in this important market.
‘This expansion reinforces our leading position in emerging markets and gives patients and healthcare professionals in Turkey access to reliable, high-quality pharmaceuticals.’ added Mine Ozturk, Country Manager for Turkey.
For further information on the agreement to acquire parts of Takeda’s Primary Care portfolio in selected emerging markets, please read the media release here.
Our Acino team in Iraq arranged the very first meeting with healthcare professionals since the liberation of Mosul in July 2017.
Acino is the number one pharmaceutical retail company in Iraq and enjoys an excellent reputation as a reliable partner for high-quality products among healthcare professionals across the country. Despite the particularly difficult situation in Iraq, the Acino team ensure goods delivery to meet patient demand every single day – and so the team was ready to deliver products to Mosul immediately after it was declared free of ISIS.
The liberation of Mosul is a critical milestone in the global fight against ISIS, and underscores the success of the international effort led by the Iraqi Security Forces. During ISIS’s occupation of Mosul, it terrorized and brutally murdered thousands of civilians, used mosques, schools and hospitals as bomb-building facilities and fighting positions.
Though the military crisis is over, around 1 million people living in Mosul have not overcome the humanitarian crisis yet. Of 54 districts in Mosul, 15 are heavily, 23 moderately destroyed.
In spite of challenging conditions and poor infrastructure, our team in Iraq delivered first products to the area within a couple of days after the liberation and held a meeting with healthcare professionals to discuss the future and how Acino will participate in supporting health institutions in the city to get back to normal operations soon.
I was waiting for first activity in Mosul and I am not surprised to see Acino to be the starter for these events.
Dr. Ahmed Moyaser Al Sofi (an Orthopaedist who came from Erbil to attend this activity)
Before the occupation by ISIS, Acino had a big team in Mosul and is now building up its presence again. Under Iraqi leadership, the United States and coalition partners will continue to work closely with the UN to stabilize liberated areas throughout Mosul, supporting the return of displaced civilians to their homes.
Acino is on the ground to ensure medical supply and education of healthcare professionals for a healthier tomorrow in Mosul!
Acino is always ahead in this field.
Dr. Laith Abdul Aziz (Head of Nineveh Health Directorate)
We congratulate the team for this outstanding achievement!
Our in-depth knowledge of our markets enables us to adapt to local needs. With a team of over 70 employees in 15 French-speaking countries in West and Central Africa, Acino has an impressive footprint in this region. The area is highly diversified with over 240 million people living in a mix of oil-exporting countries and middle to low income countries.
The strength of our teams on the ground is their close connection to local reality. We know the different challenges and opportunities in our markets and have the flexibility to adapt to changes rapidly.
Annette Ake, Cluster Head French speaking West Africa
The rainy season for example triggers diseases like malaria and Acino adapts its portfolio to seasonal as well as geographical needs. As most countries in the area are out-of-pocket markets agricultural activities can influence Acino’s demand planning like the beginning of the cocoa harvest season in Ivory Coast for example.
Acino is particularly well positioned with it antispasmodic agent Spasfon being ranked 6 in the overall top 10 market products with a market share of 58% percent in its segment. The disease burden is currently dominated by infectious diseases but current trends show a transition towards more and more chronic diseases and with its product range Acino is well positioned to respond to this demand.
But it is not only Acino’s local connections and our product portfolio which distinguishes us from competitors. As a Swiss-based company it is a matter of course that our teams on the ground apply the highest ethical standards to their relationships with health care professionals and other local partners in everything they do.
Acino’s team in Saudi-Arabia (KSA) is particularly close to the market and permanently seek to provide additional support to health care specialists. Every single member of our Medical Representatives in KSA has a medical qualification so they are able to offer even more than high-quality products.
We go further to help meet patient and physician needs. In 2016 the team used its experience to develop and distribute a brochure that promotes a holistic approach to relieving back pain. This simple brochure presents several easy stretches and exercise tips that everyone can do to help recovery from injury or pain – giving physicians another tool to help patients.
We are not just selling a product, what we are really able to do is help doctors to achieve their aims of relieving patients’ pain.
Amr El-Deeb, Senior Product Manager (and qualified Pharmacist)
This is just one example of the benefits of working with Acino. Our Medical Representatives are thinking innovatively every day to come up with the next solution that will make an impact for patients.
Acino Middle East, Turkey & Africa is managed through our Regional Office in Dubai. We have highly professional local teams in our markets with a sales force of nearly 500 medical sales representatives and strong distribution partnerships across the region. We sell under the brand name Acino Switzerland.
Driven by passion and committed to quality, our teams have a wealth of experience and in-depth knowledge of a large number of markets that might be difficult to access. Our approach is driven by the highest ethical and compliance standards which we apply to all our relationships with customers, partners and employees.
Through our teams in Middle East, Turkey and Africa, Acino aspires to become a preferred brand for patients and healthcare professionals in these emerging markets.
Building 24, 2nd Floor, Office #. 204
Dubai Healthcare City
Post Box 505296
Dubai, United Arab Emirates
Phone +971 4 556 5444